CD47 in the Brain and Neurodegeneration: An Update on the Role in Neuroinflammatory Pathways
CD47 is a receptor belonging to the immunoglobulin (Ig) superfamily and broadly expressed on cell membranes. Through interactions with ligands such as SIRPα, TSP-1, integrins, and SH2-domain bearing protein tyrosine phosphatase substrate-1 (SHPS-1), CD47 regulates numerous functions like cell adhesi...
Main Authors: | Seyed Mohammad Gheibihayat, Ricardo Cabezas, Nikita G. Nikiforov, Tannaz Jamialahmadi, Thomas P. Johnston, Amirhossein Sahebkar |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-06-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/26/13/3943 |
Similar Items
-
Overcoming immunotherapeutic resistance in PDAC: SIRPα-CD47 blockade
by: Abdullahi Alausa, et al.
Published: (2022-07-01) -
Role of CD47-SIRPα Checkpoint in Nanomedicine-Based Anti-Cancer Treatment
by: Haiqin Liao, et al.
Published: (2022-04-01) -
Targeting CD47 as a therapeutic strategy: A common bridge in the therapy of COVID-19-related cancers
by: Milad Zandi, et al.
Published: (2023-07-01) -
Cancer Therapy Targeting CD47/SIRPα
by: Nazli Dizman, et al.
Published: (2021-12-01) -
Research Progress on Relation Between CD47 and Immunotherapy on Lymphoma
by: LUO Yiyang, et al.
Published: (2021-08-01)